CRL CIK: 1100682

Charles River Laboratories International, Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
1.27
FY22:
1.44
FY23:
1.61
FY24:
1.40
FY25:
1.45
(positive)
Change from FY21 to FY25
billions USD
FY21:
5.75
FY22:
6.16
FY23:
6.59
FY24:
6.13
FY25:
5.69
Total assets
Change from FY21 to FY25
billions USD
FY21:
7.02
FY22:
7.60
FY23:
8.20
FY24:
7.53
FY25:
7.14

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
1.03
FY22:
1.09
FY23:
1.06
FY24:
0.99
FY25:
1.12
(negative)
Change from FY21 to FY25
billions USD
FY21:
3.40
FY22:
3.49
FY23:
3.48
FY24:
3.03
FY25:
2.80
(positive)
Change from FY21 to FY25
billions USD
FY21:
2.53
FY22:
2.98
FY23:
3.60
FY24:
3.46
FY25:
3.16

All amounts in billions USD Data source:SEC EDGAR